Achieve Life Sciences, Inc.(ACHV)
Pharmaceuticals
Specialty Pharma
| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership changeShares owned | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2025-09-22 | Oki Mark K Chief Financial Officer | Sale | -50,060 | -28.12%127,940 | $2.92 | $146,175 | View SEC filing | |
| 2025-09-22 | Stewart Richard Alistair Chief Executive Officer | Sale | -129,501 | -36.01%230,116 | $2.92 | $378,143 | View SEC filing | |
| 2025-09-08 | Wan Jerry Principal Accounting Officer | Sale | -14,070 | -30.09%32,694 | $2.77 | $38,974 | View SEC filing | |
| 2025-09-08 | KING THOMAS BRAXTON Director | Sale | -139,858 | -30.74%315,142 | $2.77 | $387,407 | View SEC filing | |
| 2025-09-08 | JACOBS CINDY President & CMO | Sale | -27,629 | -19.29%115,585 | $2.77 | $76,532 | View SEC filing | |
| 2025-09-08 | Xinos Jaime Chief Commercial Officer | Sale | -20,854 | -21.89%74,432 | $2.77 | $57,766 | View SEC filing | |
| 2025-03-19 | Oki Mark K Chief Financial Officer | Purchase | +10,000 | +100.00%10,000 | $2.89 | $28,887 | View SEC filing | |
| 2025-03-19 | Stewart Richard Alistair Chieve Executive Officer | Purchase | +10,000 | +25.76%48,826 | $2.86 | $28,598 | View SEC filing | |
| 2024-03-06 | Stewart Richard Alistair Executive Chairman | Purchase | +20,000 | +106.24%38,826 | $2.29 | $45,850 | View SEC filing | |
| 2024-03-06 | Bencich John CEO | Purchase | +20,000 | +41.27%68,463 | $2.29 | $45,850 | View SEC filing | |
| 2023-06-01 | Bencich John CEO | Purchase | +5,000 | +11.50%48,463 | $5.50 | $27,500 | View SEC filing | |
| 2022-11-21 | Bencich John CEO | Purchase | +33,000 | +315.40%43,463 | N/A | N/A | View SEC filing | |
| 2021-05-27 | Bencich John CEO | Purchase | +6,000 | +134.44%10,463 | $7.00 | $42,000 | View SEC filing | |
| 2019-06-13 | ARMISTICE CAPITAL, LLC 10% Owner | Sale | -47,182 | -5.47%1,593,188 | $2.86 | $134,821 | View SEC filing | |
| 2019-06-13 | ARMISTICE CAPITAL, LLC 10% Owner | Mixed | -252,150 | -21.95%1,687,552 | $3.19 | $886,157 | View SEC filing | |
| 2019-05-28 | Stewart Richard Alistair Chairman & CEO | Purchase | +17,500 | +8.97%212,530 | $3.61 | $63,093 | View SEC filing | |
| 2016-08-23 | Bencich John CFO | Sale | -1,380 | -12.70%9,484 | $0.57 | $787 | View SEC filing | |
| 2016-06-15 | JACOBS CINDY EVP, CMO | Sale | -1,437 | -1.82%77,416 | $1.03 | $1,473 | View SEC filing | |
| 2016-06-15 | Cormack Scott Daniel President and CEO | Sale | -4,856 | -3.62%129,428 | $1.03 | $4,979 | View SEC filing | |
| 2016-03-16 | JACOBS CINDY EVP, CMO | Sale | -3,254 | -4.22%73,853 | $0.83 | $2,701 | View SEC filing | |
| 2016-03-16 | Bencich John CFO | Sale | -834 | -12.45%5,864 | $0.83 | $692 | View SEC filing | |
| 2016-03-16 | Cormack Scott Daniel President and CEO | Sale | -12,033 | -8.79%124,909 | $0.83 | $9,987 | View SEC filing | |
| 2015-08-20 | Bencich John CFO | Sale | -1,427 | -28.54%3,573 | $2.76 | $3,939 | View SEC filing | |
| 2015-06-16 | JACOBS CINDY EVP, CMO | Sale | -1,408 | -2.12%64,919 | $2.69 | $3,788 | View SEC filing | |
| 2015-06-16 | Cormack Scott Daniel President and CEO | Sale | -4,571 | -3.92%111,942 | $2.69 | $12,296 | View SEC filing |
1-25 of 67